![Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventions]()
Procedural and clinical outcomes after use of the glycoprotein IIb/IIIa inhibitor abciximab for saphenous vein graft interventionsHarskamp, Ralf E.; Hoedemaker, Niels; Newby, L. Kristin; Woudstra, Pier; Grundeken, Maik J.; Beijk, Marcel A.; Piek, Jan J.; Tijssen, Jan G.; Mehta, Rajendra H.; de Winter, Robbert J. · Cardiovascular Revascularization Medicine · 2015